Background: The paste of stem bark of (AI) has been traditionally used on wound and scar for rapid healing in Bundelkhand region of India.
Objective: In the present investigation, wound healing potential of different extracts of stem bark of AI was explored in mice model.
Materials And Methods: To study the wound healing properties in small animal model, the excision and incision wound models were used and water, ethanol-water (1:1, v/v) and ethanol extracts were applied topically (15% w/w in ointment base). In the excision wound model, wound contraction, hydroxyproline content, DNA content, protein content, and nitric oxide levels were estimated after 14 days of topical treatment along with histopathological examinations. In the incision wound model, wound breaking strength was determined after 10 days of topical application of different extracts of AI.
Results: The animals treated with water extract of AI exhibited significant increment in rate of wound contraction (93.39%, < 0.01), hydroxyproline content (13.31 ± 6.65 mg/g of dry tissue, < 0.001), DNA content (20.99 ± 0.68 μg/100 mg of tissue, < 0.01), protein content (100.53 ± 7.88 mg/g of wet tissue, < 0.01) and nitric oxide level (3.05 ± 0.03 mMol/g of tissue, < 0.001) as well as in wound breaking strength (289.40 ± 29.45 g, < 0.01) when compared with vehicle control group which was also supported by histopathological studies.
Conclusion: The water extract of stem bark of AI possesses significant wound healing property, validating its traditional use.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5538173 | PMC |
http://dx.doi.org/10.4103/0973-1296.210163 | DOI Listing |
Clin Exp Pharmacol Physiol
March 2025
Department of Endocrinology, The Second Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, People's Republic of China.
Isoferulic acid (IA), a derivative of cinnamic acid, is derived from Danshen and exhibits anticancer properties by disrupting cancer cell activities. However, its role in pancreatic cancer, the "king of cancer", was unknown. In this study, pancreatic cancer cells were subjected to treatment with IA (6.
View Article and Find Full Text PDFPharmaceutics
January 2025
Department of Nanomedicine and Advanced Technologies, California Innovations Corporation, San Diego, CA 92037, USA.
In the original publication [...
View Article and Find Full Text PDFPharmaceutics
December 2024
Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
In the original publication, there was a mistake in Figure 4 as published [...
View Article and Find Full Text PDFPharmaceutics
January 2025
Dipartimento di Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche (STEBICEF), University of Palermo, Via Archirafi 32, 90123 Palermo, Italy.
: Following tooth extraction, resveratrol (RSV) can support healing by reducing inflammation and microbial risks, though its poor solubility limits its effectiveness. This study aims to develop a solid nanocomposite by embedding RSV in lipid nanoparticles (mLNP) within a hydrophilic matrix, to the scope of improving local delivery and enhancing healing. Hydroxyapatite (HXA), often used as a bone substitute, was added to prevent post-extraction alveolus volume reduction.
View Article and Find Full Text PDFPharmaceutics
January 2025
University of Belgrade, Faculty of Technology and Metallurgy, Karnegijeva 4, 11000 Belgrade, Serbia.
To develop and evaluate graphene oxide/gelatin/alginate scaffolds for advanced wound therapy capable of mimicking the native extracellular matrix (ECM) and bio-stimulating all specific phases of the wound healing process, from inflammation and proliferation to the remodeling of damaged skin tissue in three dimensions. The scaffolds were engineered as interpenetrating polymeric networks by the crosslinking reaction of gelatin in the presence of alginate and characterized by structural, morphological, mechanical, swelling properties, porosity, adhesion to the skin tissue, wettability, and in vitro simultaneous release of the active agents. Biocompatibility of the scaffolds were evaluated in vitro by MTT test on fibroblasts (MRC5 cells) and in vivo using assay.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!